Hemodynamic and volume changes associated with captopril.
- 1 July 1980
- journal article
- abstracts
- Published by Wolters Kluwer Health in Hypertension
- Vol. 2 (4) , 576-585
- https://doi.org/10.1161/01.hyp.2.4.576
Abstract
No abstract availableThis publication has 28 references indexed in Scilit:
- Hemodynamics of a new angiotensin antagonist, [Sar1, Thr8]A II, in hypertensive man.Circulation, 1980
- Constrasts and similarities of acute hemodynamic responses to specific antagonism of angiotensin II ([Sar1, Thr8] A II) and to inhibition of converting enzyme (captopril).Circulation, 1980
- Renin, aldosterone and cardiac decompensation: Studies with an oral converting enzyme inhibitor in heart failureThe American Journal of Cardiology, 1979
- Increased Glomerular Filtration Rate after Converting-Enzyme Inhibition in Essential HypertensionNew England Journal of Medicine, 1979
- Hemodynamic and antihypertensive effects of captopril, an orally active angiotensin converting enzyme inhibitor.Hypertension, 1979
- Interruption of the renin-angiotensin system in hypertensive patients by captopril induces sustained reduction in aldosterone secretion, potassium retention and natruiresis.Hypertension, 1979
- Converting enzyme inhibition with an orally active compound in hypertensive man.Hypertension, 1978
- Antihypertensive Effect of the Oral Angiotensin Converting-Enzyme Inhibitor SQ 14225 in ManNew England Journal of Medicine, 1978
- Hemodynamic correlates of saralasin-induced arterial pressure changes.Circulation, 1978
- ALPHA‐METHYL‐DOPA (ALDOMET®) IN THE TREATMENT OF HYPERTENSIONActa Medica Scandinavica, 1968